CSL

CSL, ranking first on the list of the largest biotech companies in Australia, is a worldwide expertise biotechnology firm based in Australia that conducts research, develops, produces, and distributes medicines to treat and prevent serious human medical conditions. CSL's product lines include blood plasma derivatives, vaccines, antivenom, and cell culture reagents for use in medical and genetic research and production.

With over 32,000 employees globally, it offers life-saving medications in more than 60 countries. CSL is driven to develop and supplies a wide variety of life-saving medications for diseases such as hemophilia and primary immunological deficiencies, as well as influenza vaccinations. Its treatments are also used in cardiac surgery, organ transplantation, and burn care.

The organization is committed to innovation, as evidenced by the 1,100 devoted scientists who work every day to meet the unmet needs of patients. CSL collaborates and supports patient and medical communities as a worldwide leader by expanding access to medicines, promoting scientific knowledge, supporting future medical researchers, and engaging its employees in community service.

Founded: 1916
Headquarters: Parkville, Melbourne, Victoria, Australia
Webiste: https://www.csl.com/